These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34102011)
1. Case of type 2 diabetes mellitus with edema resulting in subcutaneous insulin resistance syndrome. Hu Y; Zhu Q; Yang X; Yan J; Shi J J Diabetes Investig; 2021 Dec; 12(12):2267-2270. PubMed ID: 34102011 [TBL] [Abstract][Full Text] [Related]
2. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy. Chakraborty PP; Biswas SN Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591 [No Abstract] [Full Text] [Related]
3. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes. Rave K; Heise T; Pfützner A; Boss AH Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744 [No Abstract] [Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial. Cohen D; Weintrob N; Benzaquen H; Galatzer A; Fayman G; Phillip M J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1047-50. PubMed ID: 14513883 [No Abstract] [Full Text] [Related]
6. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes. Okamura S; Hayashino Y; Kore-Eda S; Tsujii S Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372 [No Abstract] [Full Text] [Related]
7. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus. Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173 [TBL] [Abstract][Full Text] [Related]
9. Atypical mycobacterial infection in insulin injection sites. Yew TW; Chandran NS; Tan KB; Thai AC QJM; 2015 Aug; 108(8):673-4. PubMed ID: 25638784 [No Abstract] [Full Text] [Related]
10. Case of subcutaneous insulin resistance syndrome treated with ultra-rapid insulin lispro. Ishii T; Katayama A; Sue M; Kuribayashi R; Tenta M; Matsushita Y; Takeda M; Iseda I; Tani S; Hida K J Diabetes Investig; 2022 Mar; 13(3):588-591. PubMed ID: 34510782 [TBL] [Abstract][Full Text] [Related]
16. Improvement in severe insulin resistance with frequent injections of lispro insulin. Raine CH; Krzyston MJ; Amr M; Hydrick L J Natl Med Assoc; 1999 Jul; 91(7):410-3. PubMed ID: 10643214 [TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation. Lee SI; Narendran P BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188930 [TBL] [Abstract][Full Text] [Related]
19. Conversion from intravenous insulin to subcutaneous insulin after cardiovascular surgery: transition to target study. Shomali ME; Herr DL; Hill PC; Pehlivanova M; Sharretts JM; Magee MF Diabetes Technol Ther; 2011 Feb; 13(2):121-6. PubMed ID: 21284478 [TBL] [Abstract][Full Text] [Related]